Literature DB >> 11451207

Intramedullary spinal cord astrocytoma in adults: postoperative outcome.

M S Kim1, C K Chung, G Choe, I H Kim, H J Kim.   

Abstract

Intramedullary spinal cord astrocytomas are relatively rare and usually low-grade lesions with a long natural history. The rarity of the condition and its indolent clinical course has made the evaluation of treatment efficacy difficult. To clarify postoperative outcome and prognostic factors, we performed a retrospective analysis of intramedullary spinal cord astrocytomas in a single institute. Twenty-eight patients were surgically treated between 1978 and 1999; of median age 36 years (range, 19-68 years); nineteen patients were males and nine females. All patients presented with pain and neurological deficits. The cervical cord was involved in fifteen patients, cervico-thoracic in five, thoracic in six and thoraco-lumbar in two. Gross total removal was performed in three patients, subtotal removal in six, partial removal in fourteen and biopsy only in five. Nineteen patients received radiation therapy postoperatively. The mean follow-up period was 31.9 months (range, 0.5-184 months). Low-grade astrocytomas were found in 18 cases, anaplastic astrocytoma in three cases and glioblastomas in seven cases. The median survivals of patients with low- and high-grade astrocytoma were 184 months and 8 months, respectively (p < 0.05). The median survivals of irradiated and non-irradiated patients with low-grade astrocytoma were 184 months and 102 months. Neither the extent of resection, nor radiation influenced the survival rate. In summary, the histological grade was the most significant predictor of survival in patients with astrocytoma of the spinal cord.

Entities:  

Mesh:

Year:  2001        PMID: 11451207     DOI: 10.1023/a:1010680924975

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Prognostic factors in intramedullary astrocytomas.

Authors:  G Innocenzi; M Salvati; L Cervoni; R Delfini; G Cantore
Journal:  Clin Neurol Neurosurg       Date:  1997-02       Impact factor: 1.876

2.  Surgical treatment of spinal cord astrocytomas of childhood. A series of 19 patients.

Authors:  F Epstein; N Epstein
Journal:  J Neurosurg       Date:  1982-11       Impact factor: 5.115

3.  Intracranial metastases from malignant spinal-cord astrocytoma. Case report.

Authors:  D L Johnson; S Schwarz
Journal:  J Neurosurg       Date:  1987-04       Impact factor: 5.115

4.  Clinical and pathological analysis of spinal cord astrocytomas in children.

Authors:  E Rossitch; S M Zeidman; P C Burger; J T Curnes; C Harsh; M Anscher; W J Oakes
Journal:  Neurosurgery       Date:  1990-08       Impact factor: 4.654

Review 5.  Intramedullary spinal cord tumour associated with neurofibromatosis type 1.

Authors:  T Yagi; K Ohata; M Haque; A Hakuba
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

6.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Management of intramedullary spinal cord tumors.

Authors:  G Kopelson; R M Linggood; G M Kleinman; J Doucette; C C Wang
Journal:  Radiology       Date:  1980-05       Impact factor: 11.105

8.  Primary spinal cord tumors treated with surgery and postoperative irradiation.

Authors:  D M Garcia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

9.  Spinal cord astrocytoma: pathological and treatment considerations.

Authors:  K J Minehan; E G Shaw; B W Scheithauer; D L Davis; B M Onofrio
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

10.  A survey of 65 tumors within the spinal cord: surgical results and the importance of preoperative magnetic resonance imaging.

Authors:  J Brotchi; O Dewitte; M Levivier; D Balériaux; A Vandesteene; C Raftopoulos; J Flament-Durand; J Noterman
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

View more
  25 in total

1.  Outcome predictors and complications in the management of intradural spinal tumours.

Authors:  M D Jenkinson; C Simpson; R S Nicholas; J Miles; G F G Findlay; T J D Pigott
Journal:  Eur Spine J       Date:  2005-12-23       Impact factor: 3.134

Review 2.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

3.  Intramedullary Spinal Cord Tumors.

Authors:  Daniel C. Bowers; Bradley E. Weprin
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

4.  Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab.

Authors:  Marc C Chamberlain; Sandra K Johnston
Journal:  J Neurooncol       Date:  2010-08-01       Impact factor: 4.130

5.  Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007.

Authors:  Hadie Adams; Javier Avendaño; Shaan M Raza; Ziya L Gokaslan; George I Jallo; Alfredo Quiñones-Hinojosa
Journal:  Spine (Phila Pa 1976)       Date:  2012-05-20       Impact factor: 3.468

6.  A retrospective observational study on the treatment outcomes of 26 patients with spinal cord astrocytoma including two cases of malignant transformation.

Authors:  Seong Jun Ryu; Jong Yul Kim; Kyung Hyun Kim; Jeong Yoon Park; Sung Uk Kuh; Dong Kyu Chin; Keun Su Kim; Yong Eun Cho; Se Hoon Kim
Journal:  Eur Spine J       Date:  2016-03-16       Impact factor: 3.134

7.  Comparative analysis on the diagnosis and treatments of multisegment intramedullary spinal cord tumors between the different age groups.

Authors:  Zhen-yu Wang; Jian-jun Sun; Jing-cheng Xie; Zhen-dong Li; Chang-cheng Ma; Bin Liu; Xiao-dong Chen; Hung-I Liao; Tao Yu; Jia Zhang
Journal:  Neurosurg Rev       Date:  2011-08-06       Impact factor: 3.042

8.  Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Authors:  Mohamad H Fakhreddine; Anita Mahajan; Marta Penas-Prado; Jeffrey Weinberg; Ian E McCutcheon; Vinay Puduvalli; Paul D Brown
Journal:  Neuro Oncol       Date:  2013-01-14       Impact factor: 12.300

9.  The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.

Authors:  Deliang Wang; Li Wang; Yi Zhou; Xinjun Zhao; Hui Xiong
Journal:  Tumour Biol       Date:  2015-11-21

10.  Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study.

Authors:  Michael T Milano; Mahlon D Johnson; Joohee Sul; Nimish A Mohile; David N Korones; Paul Okunieff; Kevin A Walter
Journal:  J Neurooncol       Date:  2009-11-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.